Via well-designed AI tools and workflows, trial sponsors are aiming to unify cross-functional data ecosystems to enable a ...
Clinical Trials Arena on MSN
GSK to file for approval of hep B drug on positive Phase III data
GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.
The Juveena Hydrogel System is designed as a temporary spacer to help prevent the formation and reformation of intrauterine adhesions (IUAs). The PMA submission includes results from a pivotal ...
Septodont announces the launch of GenENDO1, a range of endodontic files designed to support easy and successful shaping of ...
Medable Inc., the leading technology platform for AI-powered clinical development, today announced its TMF Agent, which brings artificial intelligence and automation to the labor-intensive processes ...
Veradermics filed for an initial public offering. Veradermics didn't disclose the an offering price or amount of shares it would sell. It intends to trade on the New York Stock Exchange under the ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs ...
The company’s new AI agent automates labor-intensive processes involved in trial document management.
HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the ...
Clinical-stage dermatology company Veradermics filed for an initial public offering in the United States on Friday and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback